Single team visit for atypical Parkinsonian disorders
Part of Brain & nervous system clinical trials.
This study is testing whether a single appointment with a team of specialists can improve care for people with atypical Parkinsonian disorders like MSA, PSP, or CBS. You would come to the clinic once for a comprehensive visit, and researchers will see if this helps you and your care partner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have a diagnosis of Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), or Cortico-Basal Syndrome (CBS).
- You are able to visit the clinic in person.
- You do not have a serious, life-limiting medical condition (like advanced kidney disease, heart failure, or metastatic cancer).
- You live with a care partner (not in a long-term care facility or separated from them).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study involves people with possible or probable multiple system atrophy (MSA) joining a specialized clinic team and attending visits every 4 months. It’s meant to improve care planning and support by bringing different specialists together.
This study looks at genetic factors in people with PSP, CBS, MSA, or similar brain conditions, and also in their family members. It involves genetic testing to learn more about these diseases and may help find new treatments.
This study looks at how people with certain rare brain conditions (like progressive supranuclear palsy, corticobasal syndrome, or multiple system atrophy) use healthcare services and how their quality of life is affected. It may help doctors better support patients and their carers.
This study tests a remote monitoring system to track symptoms of progressive supranuclear palsy (PSP) and similar movement disorders. It may tell you how your condition changes over time without needing frequent clinic visits.
This study collects data from people with Parkinson's disease or multiple system atrophy (MSA) to better understand these conditions. You will have blood, saliva, optional spinal fluid tests, and brain scans (MRI, PET/SPECT).
This study uses brain scans and clinical check-ins to better diagnose and predict how Parkinson-related conditions may progress over time. It may help researchers find markers that explain why symptoms change, and could improve future care.
Hear when a new Parkinson Plus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.